“ME-TOO” DRUG REVOLUTION: A PRODUCT OF REGULATORY IMPROPRIETY
Journal Title: International Journal of Drug Regulatory Affairs - Year 2016, Vol 4, Issue 3
Abstract
Amidst all the brouhaha, often the regulatory agencies, for instance the United States Food and Drug Administration’s (US-FDA) role in bringing about what is being so cleverly termed as the ‘me-too drug revolution’, has escaped scrutiny. Bearing in mind the pre-eminent status of USFDA in regulatory world, it would be useful to examine some of their strategies that have helped facilitate this revolution. The surge seen in the approval of me-too drugs can be attributed to a regressive policy of evaluating a new drug against a placebo or using non-inferiority trials, which in turn has often allowed an easy rite of passage for the me-too drugs. So has the Prescription Drug User Fees Act (PDUFA) by allowing rapid approval of drugs. However, this has not necessarily translated into safer drugs! Further, advisory committees that are rife with conflicts of interest, a legally weakened status bestowed upon the USFDA and a no-holds barred approach adopted by the industry towards direct to consumer advertisements (DTCA), has allowed me-too drugs with dubious safety profiles to flourish in the markets. It has been suggested on many fronts that by undertaking measures, for instance an increment in the US congress appropriations to the US-FDA, vesting punitive powers in the agency to rein in the errant pharmaceutical companies as well as dealing with the conflicts of interest within the advisory committees could go a long way in preventing the undue and potentially dangerous proliferation of me-too drugs.
Authors and Affiliations
Bhattacharjee Dipanjan, Agarwal Saurabh
Keywords
Related Articles
- EP ID EP337004
- DOI 10.22270/ijdra.v4i3.185
- Views 131
- Downloads 0
MARKETING AUTHORIZATION APPLICATION (MAA) FOR EUROPE MARKET
This article states requirement of Marketing Authorization Application to get registration of Drug Product to EEA. The procedures for application of marketing authorization are: Centralised procedure, National procedure,...
REGULATIONS OF REGISTRATION AND IMPORT OF MEDICAL DEVICE IN INDIA
India is a huge market for medical devices and is increasing constantly for the last few years. The registration certificate and import license is mandatory for a manufacturer of India who wishes to import any medical de...
REGULATORY TECHNICALITIES FOR DRUG PRODUCT REGISTRATION IN BRAZIL
Brazilians are demanding better healthcare and modern medicines, presenting significant opportunities for foreign investment. In Brazil, medicinal product registration is an extensive process. To do business in Brazil is...
FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF FLOATING TABLETS OF LAFUTIDINE BY EMPLOYING EFFERVESCENT TECHNOLOGY
In the present research work gastro retentive floating matrix formulation of Lafutidine by using various polymers were developed. Initially analytical method development was done for the drug molecule. Absorption maxima...
A STUDY ON HEAMPHILUS INFLUANZAE TYPE B DISEASE CAUSING ANTIGENS: AN APPROACH OF EPITOPE PREDICTION, ANTIGENICITY AND IMMUNOGENICITY PREDICTION
Vaccines work by mimicking disease agents and stimulating the immune system which in turn builds a defence mechanism against the disease causing agents. Some of the vaccines contain a part of the disease causing agents w...